Tag Archives: sars-cov-2

Risk of long COVID and associated symptoms after acute SARS-COV-2 infection in ethnic minorities: A nationwide register-linked cohort study in Denmark

Posted on 20/02/2024 by

by George Frederick Mkoma, Charles Agyemang, Thomas Benfield, Mikael Rostila, Agneta Cederström, Jørgen Holm Petersen, Marie Norredam Background Ethnic minorities living in high-income countries have been disproportionately affected by Coronavirus Disease 2019 (COVID-19) in terms of infection rates, hospitalisations, and … Continue reading →

Posted in Uncategorized | Tagged , , , , , , , , , , , , , , , , , | Comments Off on Risk of long COVID and associated symptoms after acute SARS-COV-2 infection in ethnic minorities: A nationwide register-linked cohort study in Denmark

Long-term vaccination strategies to mitigate the impact of SARS-CoV-2 transmission: A modelling study

Posted on 22/01/2024 by

by Alexandra B. Hogan, Sean L. Wu, Jaspreet Toor, Daniela Olivera Mesa, Patrick Doohan, Oliver J. Watson, Peter Winskill, Giovanni Charles, Gregory Barnsley, Eleanor M. Riley, David S. Khoury, Neil M. Ferguson, Azra C. Ghani Background Vaccines have reduced severe … Continue reading →

Posted in Uncategorized | Tagged , , , , , , , , , , | Comments Off on Long-term vaccination strategies to mitigate the impact of SARS-CoV-2 transmission: A modelling study

Intensified screening for SARS-CoV-2 in 18 emergency departments in the Paris metropolitan area, France (DEPIST-COVID): A cluster-randomized, two-period, crossover trial

Posted on 22/01/2024 by

by Judith Leblanc, Lisbeth Dusserre-Telmon, Anthony Chauvin, Tabassome Simon, Chiara E. Sabbatini, Karla Hemming, Vittoria Colizza, Laurence Bérard, Jérome Convert, Sonia Lazazga, Carole Jegou, Nabila Taibi, Sandrine Dautheville, Damien Zaghia, Camille Gerlier, Muriel Domergue, Florine Larrouturou, Florence Bonnet, Arnaud Fontanet, … Continue reading →

Posted in Uncategorized | Tagged , , , , , , , , , , , , , , , , | Comments Off on Intensified screening for SARS-CoV-2 in 18 emergency departments in the Paris metropolitan area, France (DEPIST-COVID): A cluster-randomized, two-period, crossover trial